Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 1.850
+0.025 (1.37%)
Feb 10, 2026, 5:15 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 449.06 million as of February 10, 2026. Its market cap has increased by 39.68% in one year.
Market Cap
449.06M
Enterprise Value
417.28M
Revenue
52.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.85
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 449.06M, an increase of 312.25%. That is a compound annual growth rate of 10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 442.99M | -3.95% |
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 2.10B |
| EQL Pharma AB | 1.82B |
| Orexo AB | 976.50M |
| Cinclus Pharma Holding AB | 784.63M |
| Dicot Pharma AB | 661.07M |
| Nanexa AB | 592.66M |
| Moberg Pharma AB | 430.29M |
| Klaria Pharma Holding AB (publ.) | 243.02M |